These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2450966)

  • 1. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus.
    Becht H; Müller H; Müller HK
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():631-40. PubMed ID: 2450966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to the 32K structural protein of infectious bursal disease virus neutralizes viral infectivity in vitro and confers protection on young chickens.
    Fahey KJ; O'Donnell IJ; Bagust TJ
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2693-702. PubMed ID: 2999312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens.
    Fahey KJ; Erny K; Crooks J
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1473-81. PubMed ID: 2543787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization by Western blotting of the immunogens of infectious bursal disease virus.
    Fahey KJ; O'Donnell IJ; Azad AA
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1479-88. PubMed ID: 2410555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural polypeptide VP3 of infectious bursal disease virus carries group- and serotype-specific epitopes.
    Oppling V; Müller H; Becht H
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2275-8. PubMed ID: 1716656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates.
    Snyder DB; Lana DP; Savage PK; Yancey FS; Mengel SA; Marquardt WW
    Avian Dis; 1988; 32(3):535-9. PubMed ID: 2461698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus.
    Oppling V; Müller H; Becht H
    Arch Virol; 1991; 119(3-4):211-23. PubMed ID: 1715158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.
    Fahey KJ; McWaters P; Brown MA; Erny K; Murphy VJ; Hewish DR
    Avian Dis; 1991; 35(2):365-73. PubMed ID: 1713030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and antigenicity of infectious bursal disease virus serotypes I and II in chickens.
    Jackwood DJ; Saif YM; Moorhead PD
    Avian Dis; 1985; 29(4):1184-94. PubMed ID: 3008699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic structure analysis of VP3 of infectious bursal disease virus.
    Deng X; Gao Y; Gao H; Qi X; Cheng Y; Wang X; Wang X
    Virus Res; 2007 Oct; 129(1):35-42. PubMed ID: 17590471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to infectious pancreatic necrosis virus: analysis of viral epitopes and comparison of different isolates.
    Caswell-Reno P; Reno PW; Nicholson BL
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2193-205. PubMed ID: 2428927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against different epitopes of a 40 Kd capsid protein of infectious bursal disease viruses.
    Lee LH
    Proc Natl Sci Counc Repub China B; 1990 Apr; 14(2):75-84. PubMed ID: 1701058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus.
    Schnitzler D; Bernstein F; Müller H; Becht H
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1563-71. PubMed ID: 7688411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antigen variation on the quantitative agar gel precipitin test for antibodies to infectious bursal disease virus.
    Wood GW; Muskett JC; Reed NE; Thornton DH
    J Biol Stand; 1984 Jul; 12(3):311-4. PubMed ID: 6207175
    [No Abstract]   [Full Text] [Related]  

  • 15. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.
    Yamaguchi T; Iwata K; Kobayashi M; Ogawa M; Fukushi H; Hirai K
    Arch Virol; 1996; 141(8):1493-507. PubMed ID: 8856029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of maternally derived infectious bursal disease antibodies to serotypes 1 and 2 to protect against heterologous virus.
    Chettle NJ; Wyeth PJ
    Br Vet J; 1989; 145(2):165-9. PubMed ID: 2540872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neutralizing antigens of recent isolates of infections bursal disease virus.
    Reddy SK; Silim A
    Arch Virol; 1991; 117(3-4):287-96. PubMed ID: 1850233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.
    Snyder DB; Vakharia VN; Savage PK
    Arch Virol; 1992; 127(1-4):89-101. PubMed ID: 1333761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.
    Snyder DB; Lana DP; Cho BR; Marquardt WW
    Avian Dis; 1988; 32(3):527-34. PubMed ID: 2848486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of susceptible versus immune chicks to killed, live-modified, and wild infectious bursal disease virus vaccines.
    Lucio B; Hitchner SB
    Avian Dis; 1979; 23(4):1037-50. PubMed ID: 232653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.